CLN — Celon Pharma SA Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Annual cashflow statement for Celon Pharma SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.

	2019 December 31st	R2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	PAS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	11.9	-5.59	-15.1	-36.4	-20
Depreciation
Non-Cash Items	-0.504	0.767	3.63	-4.62	-8.27
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-37.1	44.8	14.1	-7.73	-30.1
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities	-5.05	71.7	44	-4.7	-8.31
Capital Expenditures	-65	-99.5	-41.4	-33.9	-32.8
Purchase of Fixed Assets
Other Investing Cash Flow Items	-2.78	46.2	-79.7	2.43	11.2
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-67.7	-53.3	-121	-31.5	-21.6
Financing Cash Flow Items	-0.174	-0.586	-14.3	-1.5	-2.62
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-8.52	4.25	181	-28.7	-20.6
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-81.3	22.7	104	-64.9	-50.5